For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250331:nRSe9244Ca&default-theme=true
RNS Number : 9244C Consort Healthcare (Tameside) PLC 31 March 2025
CONSORT HEALTHCARE (TAMESIDE) PLC
The outstanding 1.9810 per cent. Index-Linked Guaranteed Secured Bonds due
2041
unconditionally and irrevocably guaranteed as to scheduled payments of
principal and interest (adjusted for indexation) pursuant to a bond financial
guarantee issued by Ambac Assurance UK Limited ("Ambac")
ISIN XS0321115130
(the "Notes")
SETTLEMENTS WITH THE TAMESIDE & GLOSSOP INTEGRATED CARE NHS FOUNDATION
TRUST AND EQUANS SERVICES LIMITED
London, 31 March 2025 - Consort Healthcare (Tameside) plc (the "Company"), a
project company for the Private Finance Initiative (PFI) concession contract
to design, construct, finance, maintain and manage the lifecycle costs of
hospital facilities in Tameside for the Tameside & Glossop Integrated Care
NHS Foundation Trust (the "Trust") provides the following update regarding
settlements reached between the Company and each of the Trust and Equans
Services Limited.
In this announcement, words and expressions defined (expressly or by
reference) or interpreted in the trust deed constituting the Notes shall,
unless otherwise defined herein, bear the same meaning herein.
As previously announced on 10 December 2024, the Company has been in
discussions with Ambac (the Bond Financial Guarantor and Controlling Creditor)
in relation to a package of short to medium term relaxations and/or waivers of
the existing financial covenant requirements to support the deed of amendment
and variation entered into with the Trust and the separate deed of
settlement and variation in relation to the FM Service Contract with Equans
Services Limited. The Company has now entered into a global deed of
amendment to put these necessary relaxations in place with the first test
dates being 30 September 2025.
This announcement is given by the Company.
Enquiries: consorttameside@vercitygroup.com
(mailto:consorttameside@vercitygroup.com)
THIS ANNOUNCEMENT CONTAINS INFORMATION THAT QUALIFIES OR MAY HAVE QUALIFIED AS
INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7 OF THE MARKET ABUSE
REGULATION (EU NO. 596/2014), AS IT FORMS PART OF UNITED KINGDOM DOMESTIC LAW
BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END STRGCGDXBSXDGUB